Drugs/Medicines usually entice primary customs obligation of 10 per cent, whereas some classes of life saving medication/vaccines entice a concessional fee of 5 per cent or Nil.
The import obligation waiver will come into impact from April 1.
The authorities has exempted primary customs obligation on all medication and meals for particular medical functions imported for private use for therapy of uncommon ailments.
The import obligation waiver will come into impact from April 1.
Also, the federal government has exempted Pembrolizumab (Keytruda), utilized in therapy of assorted cancers, from primary customs obligation.
Drugs/Medicines usually entice primary customs obligation of 10 per cent, whereas some classes of life saving medication/vaccines entice a concessional fee of 5 per cent or Nil.
“The Central Government has given full exemption from primary customs obligation on all medication and Food for Special Medical Purposes imported for private use for therapy of all Rare Diseases listed below the National Policy for Rare Diseases 2021,” a finance ministry statement said.
Food for Special Medical Purposes is a food formulation intended to provide nutritional support to persons who suffer from a specific disease, disorder or a medical condition, as a part of their dietary management.
In order to avail this exemption, the individual importer has to produce a certificate from Central or State Director Health Services or District Medical Officer/Civil Surgeon of the district.
While exemptions have already been provided to specified drugs for treatment of Spinal Muscular Atrophy or Duchenne Muscular Dystrophy, the government has been receiving many representations seeking customs duty relief for drugs and medicines used in treatment of other rare diseases.
Drugs or Special Foods required for the treatment of these diseases are expensive and need to be imported.
The ministry said it is estimated that for a child weighing 10 kg, the annual cost of treatment for some rare diseases, may vary from Rs 10 lakh to more than Rs 1 crore per year with treatment being lifelong and drug dose and cost, increasing with age and weight.
“This exemption will result in substantial cost savings and provide much needed relief to the patients,” the ministry mentioned.
Read all of the Latest Business News right here
(This story has not been edited by News18 workers and is printed from a syndicated information company feed)
